Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound

Pancreas

Volumn 43, Issue 3, 2014, Pages 458-461

  Sud, Anchal ^a   Wham, Deborah ^a   Catalano, Marc ^a   Guda, Nalini M ^a,b  

^a ST LUKE S MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Endoscopic ultrasound; Familial pancreatic cancer; Genetic counseling; Screening

Indexed keywords

BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL ARTICLE; ENDOSCOPIC ECHOGRAPHY; FAMILY HISTORY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GASTROENTEROLOGIST; GENETIC COUNSELING; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MIDDLE AGED; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CYST; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; ADENOCARCINOMA; BREAST NEOPLASMS; COHORT ANALYSIS; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; GENETICS; METABOLISM; MUTATION; OUTCOME ASSESSMENT; PANCREAS; PANCREAS CARCINOMA; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; EARLY DETECTION OF CANCER; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; ENDOSONOGRAPHY; FEMALE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUTATION; OUTCOME ASSESSMENT (HEALTH CARE); PANCREAS; PANCREATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84896669537     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000052     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute.
3. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
4. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212.
5. Klein AP, Hruban RH, Brune KA, et al. Familial pancreatic cancer. Cancer J. 2001;7:266-273.
6. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 2001;7:738.
7. Brentnall TA. Management strategies for patients with hereditary pancreatic cancer. Curr Treat Options Oncol. 2005;6:437.
8. Fourth International Symposium of Inherited Diseases of the Pancreas. November 7-9, 2003. Chicago, IL. Pancreatology. 2003;3(6):520-532.
9. Brand RE, Lerch MM, Rubinstein WS, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut. 2007;56:1460-1469.
10. Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: A prospective controlled study. Clin Gastroenterol Hepatol. 2006;4:766-781.
11. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach. Clin Gastroenterol Hepatol. 2004;2:606-621.
12. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 1999;131:247-255.
13. Canto MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol. 2007;34:295-302.
14. Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142:796-804.
15. Poley JW, Kluijt I, Gouma DJ, et al. The yield of first-Time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol. 2009;104:2175-2181.
16. Ludwig E, Olson SH, Bayuga S, et al. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol. 2011;106:946-954.
17. Vasen HF, Wasser M, van Mil A, et al. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology. 2011;140:850-856.
18. Eloubeidi MA, Chen VK, Eltoum IA, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: Diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98:2663-2668.
19. Fritscher-Ravens A, Knoefel WT, Krause C, et al. Three-dimensional linear endoscopic ultrasoundVfeasibility of a novel technique applied for the detection of vessel involvement of pancreatic masses. Am J Gastroenterol. 2005;100:1296-1302.
20. Ahmad NA, Kochman ML, Brensinger C, et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc. 2003;58:59-64.